Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
O96005 | Putative lipid scramblase CLPTM1 | ||
P00450 | Ceruloplasmin | ||
P00734 | Prothrombin | ||
P00740 | Coagulation factor IX | ||
P00742 | Coagulation factor X | ||
P00747 | Plasminogen | ||
P00748 | Coagulation factor XII | ||
P00749 | Urokinase-type plasminogen activator | ||
P00750 | Tissue-type plasminogen activator | ||
P00751 | Complement factor B |
Pathway Name | Organism |
---|---|
E.coli O128ac | Escherichia coli |
E.coli O138 | Escherichia coli |
E.coli O142 | Escherichia coli |
E.coli O154 | Escherichia coli |
E.coli O157 | Escherichia coli |
E.coli O158ab | Escherichia coli |
E.coli O166 | Escherichia coli |
E.coli O176 | Escherichia coli |
E.coli O184 | Escherichia coli |
E.coli O185 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
28025250 | Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen | Movahedin M | 2016 Dec 26 |
|
27907170 | Complementation of an aglB Mutant of Methanococcus maripaludis with Heterologous Oligosaccharyltransferases | Ding Y | 2016 Dec 01 |
|
27736776 | Dynamic Interactions of a Conserved Enterotoxigenic Escherichia coli Adhesin with Intestinal Mucins Govern Epithelium Engagement and Toxin Delivery | Kumar P | 2016 Dec |
|
27387336 | Exposure to siRNA-GalNAc Conjugates in Systems of the Standard Test Battery for Genotoxicity | Janas MM | 2016 Dec |
|
27616150 | Entamoeba histolytica : Overexpression of the gal/galnac lectin, ehcp2 and ehcp5 genes in an in vivo model of amebiasis | Sánchez V | 2016 Dec |
|
27500733 | Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys | Yu RZ | 2016 Dec |
|
27178902 | Sulfation pattern of fucose branches affects the anti-hyperlipidemic activities of fucosylated chondroitin sulfate | Wu N | 2016 Aug 20 |
|
27599733 | Re-evaluation of low-resolution crystal structuresviainteractive molecular-dynamics flexible fitting (iMDFF): a case study in complement C4 | Croll TI | 2016 Aug 18 |
|
27538840 | Evaluation of an amino acid residue critical for the specificity and activity of human Gb3/CD77 synthase | Kaczmarek R | 2016 Aug 18 |
|
27526028 | Structural basis of laminin binding to the LARGE glycans on dystroglycan | Briggs DC | 2016 Aug 15 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025